3 Biotech Cos. Raise $543M In Upsized Nasdaq Debuts
Three biotechnology companies focused on areas such as treatments for cancer and chronic diseases all began trading on the Nasdaq on Friday after collectively raising nearly $543 million in upsized initial...To view the full article, register now.
Already a subscriber? Click here to view full article